Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
Crossref DOI link: https://doi.org/10.1007/s12640-017-9781-2
Published Online: 2017-07-21
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zakrocka, Izabela
Targowska-Duda, Katarzyna M.
Wnorowski, Artur
Kocki, Tomasz
Jóźwiak, Krzysztof
Turski, Waldemar A.
Funding for this research was provided by:
Narodowe Centrum Nauki (PRELUDIUM 4, No UMO-2012/07/N/NZ4/02088)
License valid from 2017-07-21